BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ethionamide

A second-line antitubercular agent that inhibits mycolic acid synthesis.

298+ PubMed studies analyzed · 6 RCTs · Evidence Score: 42.6

Research Domains

Ethionamide has been studied across 11 research domains including 🫁 Respiratory, 🫁 Liver & Detox, 🧠 Focus & Attention, 🧬 Hormones, 🫘 Kidney. The primary research focus is 🫁 Respiratory with 31% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ethionamide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lactic
4 shared targets
Meropenem
3 shared targets
propyl
6 shared targets
Propanil
5 shared targets
Chlormethiazole
3 shared targets
Mephenesin
3 shared targets
Piperazine
4 shared targets
Orotic
3 shared targets
Acrylamide
3 shared targets
DEET
3 shared targets
Loading evidence profile...

This evidence profile for Ethionamide is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.